An insight into the role of arachidonic acid derived lipid mediators in virus associated pathogenesis and malignancies

Prostaglandins & Other Lipid Mediators - Tập 126 - Trang 46-54 - 2016
Jayashree A. Chandrasekharan1, Alexandru Marginean1, Neelam Sharma-Walia1
1Department of Microbiology and Immunology, H.M. Bligh Cancer Research Laboratories, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA

Tài liệu tham khảo

Murakami, 2016, Lipid mediators in life science, Exp. Anim., 60, 7, 10.1538/expanim.60.7

Quehenberger, 2016, The human plasma lipidome, N. Engl. J. Med., 365, 1812, 10.1056/NEJMra1104901

Fahy, 2009, Update of the LIPID MAPS comprehensive classification system for lipids, J. Lipid Res., 50, S9, 10.1194/jlr.R800095-JLR200

Fahy, 2005, A comprehensive classification system for lipids, J. Lipid Res., 46, 839, 10.1194/jlr.E400004-JLR200

Medzhitov, 2008, Origin and physiological roles of inflammation, Nature, 454, 428, 10.1038/nature07201

Samuelsson, 1991, Arachidonic acid metabolism: role in inflammation, Z. Rheumatol., 50, 3

Das, 2016, Lipoxins as biomarkers of lupus and other inflammatory conditions, Lipids Health Dis., 10, 76, 10.1186/1476-511X-10-76

Greene, 2016, Regulation of inflammation in cancer by eicosanoids, Prostaglandins Other Lipid Mediat., 96, 27, 10.1016/j.prostaglandins.2011.08.004

Oates, 1982, The 1982 nobel prize in physiology or medicine, Science, 218, 765, 10.1126/science.6753151

von Euler, 1936, On the specific vaso-dilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin), J. Physiol., 88, 213, 10.1113/jphysiol.1936.sp003433

Bos, 2004, Prostanoids and prostanoid receptors in signal transduction, Int. J. Biochem. Cell Biol., 36, 1187, 10.1016/j.biocel.2003.08.006

Versteeg, 1999, Cyclooxygenase-dependent signalling: molecular events and consequences, FEBS Lett., 445, 1, 10.1016/S0014-5793(99)00105-2

Saunders, 2016, Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution, J. Biol. Chem., 286, 30130, 10.1074/jbc.M111.246884

Yung, 2014, LPA receptor signaling: pharmacology, physiology, and pathophysiology, J. Lipid Res., 55, 1192, 10.1194/jlr.R046458

Kohli, 2009, Resolvins and protectins: mediating solutions to inflammation, Br. J. Pharmacol., 158, 960, 10.1111/j.1476-5381.2009.00290.x

Poorani, 2015, COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance, Eur. J. Pharmacol.

Das, 2005, Can COX-2 inhibitor-induced increase in cardiovascular disease risk be modified by essential fatty acids?, J. Assoc. Phys. India, 53, 623

Das, 2005, COX-2 inhibitors and metabolism of essential fatty acids, Med. Sci. Monit., 11, RA233

Gronert, 2001, Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses, Am. J. Pathol., 158, 3, 10.1016/S0002-9440(10)63937-5

Schaldach, 1999, Lipoxin A4: a new class of ligand for the Ah receptor, Biochemistry, 38, 7594, 10.1021/bi982861e

Russell, 2011, Lipoxin A4 is a novel estrogen receptor modulator, FASEB J., 25, 4326, 10.1096/fj.11-187658

Keinan, 2013, Understanding resolvin signaling pathways to improve oral health, Int. J. Mol. Sci., 14, 5501, 10.3390/ijms14035501

Wang, 2016, ALX/FPR2 modulates anti-inflammatory responses in mouse submandibular gland, Sci. Rep., 6, 24244, 10.1038/srep24244

Nelson, 2014, ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands, Am. J. Physiol. Cell Physiol., 306, C178, 10.1152/ajpcell.00284.2013

Siqueira Mietto, 2015, Role of IL-10 in resolution of inflammation and functional recovery after peripheral nerve injury, J. Neurosci., 35, 16431, 10.1523/JNEUROSCI.2119-15.2015

Murakami, 2011, Lipid mediators in life science, Exp. Anim., 60, 7, 10.1538/expanim.60.7

Maskrey, 2011, Mechanisms of resolution of inflammation: a focus on cardiovascular disease, Arterioscler. Thromb. Vasc. Biol., 31, 1001, 10.1161/ATVBAHA.110.213850

Dasgupta, 2012, Contribution of alternatively activated macrophages to allergic lung inflammation: a tale of mice and men, J. Innate Immun., 4, 478, 10.1159/000336025

Zhang, 2007, Cytokines, inflammation and pain, Int. Anesthesiol. Clin., 45, 27, 10.1097/AIA.0b013e318034194e

Khovidhunkit, 2004, Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host, J. Lipid Res., 45, 1169, 10.1194/jlr.R300019-JLR200

Serhan, 2005, Resolution of inflammation: the beginning programs the end, Nat. Immunol., 6, 1191, 10.1038/ni1276

Linkous, 2016, Cytosolic phospholipase A2 as a mediator of disease pathogenesis, Cell. Microbiol., 12, 1369, 10.1111/j.1462-5822.2010.01505.x

Linkous, 2016, Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis, J. Natl. Cancer Inst., 102, 1398, 10.1093/jnci/djq290

Hwang, 1998, Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer, J. Natl. Cancer Inst., 90, 455, 10.1093/jnci/90.6.455

Hida, 1998, Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas, Cancer Res., 58, 3761

Maaser, 2003, Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis, Br. J. Cancer, 88, 1217, 10.1038/sj.bjc.6600865

Lin, 2002, Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer, Head Neck, 24, 792, 10.1002/hed.10108

Jakobsson, 1995, The 5-lipoxygenase pathway in normal and malignant human B lymphocytes, Adv. Prostag. Thromb. Leukot. Res., 23, 293

Levy, 1997, Prostaglandin H synthases nonsteroidal anti-inflammatory drugs, and colon cancer, FASEB J., 11, 234, 10.1096/fasebj.11.4.9068612

Anderson, 1998, Five-lipoxygenase inhibitors reduce Panc-1 survival: the mode of cell death and synergism of MK886 with gamma linolenic acid, Anticancer Res., 18, 791

Anderson, 1995, Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induce limited differentiation and apoptosis, Leuk. Res., 19, 789, 10.1016/0145-2126(95)00043-7

Anderson, 1998, Inhibition of cancer cell proliferation by disruption of interdigitated/concatenated hierarchies of metabolic control/implementation processes: a proposal, Med. Hypotheses, 50, 119, 10.1016/S0306-9877(98)90196-7

Ghosh, 1998, Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells, Proc. Natl. Acad. Sci. U. S. A., 95, 13182, 10.1073/pnas.95.22.13182

Rioux, 1998, Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents, Carcinogenesis, 19, 1393, 10.1093/carcin/19.8.1393

Hennig, 2002, 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue, Am. J. Pathol., 161, 421, 10.1016/S0002-9440(10)64198-3

Soumaoro, 2006, Expression of 5-lipoxygenase in human colorectal cancer, World J. Gastroenterol., 12, 6355, 10.3748/wjg.v12.i39.6355

Tong, 2005, LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways, Biochem. Biophys. Res. Commun., 335, 949, 10.1016/j.bbrc.2005.07.166

Bortuzzo, 1996, The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells, Biochim. Biophys. Acta, 1300, 240, 10.1016/0005-2760(96)00003-3

Zhang, 2012, Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice, Diabetologia, 55, 183, 10.1007/s00125-011-2304-4

Ding, 2005, A novel anti-pancreatic cancer agent, LY293111, Anticancer Drugs, 16, 467, 10.1097/00001813-200506000-00001

Ding, 2005, PGE2 up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system, Exp. Oncol., 27, 108

Wang, 2007, Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway, Mol. Carcinog., 46, 912, 10.1002/mc.20320

Paul, 2013, Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines, Transl. Res., 161, 447, 10.1016/j.trsl.2013.02.008

Paul, 2013, Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies, Transl. Res., 162, 77, 10.1016/j.trsl.2013.03.004

Sharma-Walia, 2012, COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP, Oncogenesis, 1, e5, 10.1038/oncsis.2012.5

Paul, 2011, Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma, PLoS One, 6, e24379, 10.1371/journal.pone.0024379

George Paul, 2010, Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen, Cancer Res., 70, 3697, 10.1158/0008-5472.CAN-09-3934

Sharma-Walia, 2010, NFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2), J. Virol., 84, 12733, 10.1128/JVI.01065-10

Sharma-Walia, 2006, Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression, J. Virol., 80, 6534, 10.1128/JVI.00231-06

Belfiore, 2007, Involvement of 5-lipoxygenase in survival of Epstein-Barr virus (EBV)-converted B lymphoma cells, Cancer Lett., 254, 236, 10.1016/j.canlet.2007.03.010

Sharma-Walia, 2010, Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion, PLoS Pathog., 6, e1000777, 10.1371/journal.ppat.1000777

Sharma-Walia, 2014, The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis, J. Virol., 88, 2131, 10.1128/JVI.02786-13

Pace, 2004, LTB4 is present in exudative pleural effusions and contributes actively to neutrophil recruitment in the inflamed pleural space, Clin. Exp. Immunol., 135, 519, 10.1111/j.1365-2249.2003.02387.x

Gertner, 1994, Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis, Gut, 35, 1429, 10.1136/gut.35.10.1429

Takematsu, 1987, Leukocyte chemotactic properties of soluble horny contents in epidermal cysts, Arch. Dermatol. Res., 279, 449, 10.1007/BF00412590

Shan, 2010, Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2, Cell Res., 20, 563, 10.1038/cr.2010.49

Zhang, 2012, Myostatin-null mice exhibit delayed skin wound healing through the blockade of transforming growth factor-beta signaling by decorin, Am. J. Physiol. Cell Physiol., 302, C1213, 10.1152/ajpcell.00179.2011

Rola-Pleszczynski, 1985, Differential effects of leukotriene B4 on T4+ and T8+ lymphocyte phenotype and immunoregulatory functions, J. Immunol., 135, 1357, 10.4049/jimmunol.135.2.1357

Rola-Pleszczynski, 1985, Leukotrienes augment interleukin 1 production by human monocytes, J. Immunol., 135, 3958, 10.4049/jimmunol.135.6.3958

Wahl, 1989, Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1, Proc. Natl. Acad. Sci. U. S. A., 86, 621, 10.1073/pnas.86.2.621

Lipschik, 1993, Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease, Chest, 104, 763, 10.1378/chest.104.3.763

Volovitz, 1988, Release of leukotriene C4 in respiratory tract during acute viral infection, J. Pediatr., 112, 218, 10.1016/S0022-3476(88)80058-1

Medina, 1990, Human fibroblasts show expression of the leukotriene-A4-hydrolase gene, which is increased after simian-virus-40 transformation, Eur. J. Biochem., 191, 27, 10.1111/j.1432-1033.1990.tb19089.x

Kasirga, 1999, Blood levels of leukotrienes (LTC4, D4, E4, B4) and synthesis of leukotriene B4 by peripheral leukocytes in children with acute A and B hepatitis, Turk. J. Pediatr., 41, 457

Doria, 2012, Lipidomic approach to identify patterns in phospholipid profiles and define class differences in mammary epithelial and breast cancer cells, Breast Cancer Res. Treat., 133, 635, 10.1007/s10549-011-1823-5

Pyne, 2011, Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules, Cancer Res., 71, 6576, 10.1158/0008-5472.CAN-11-2364

O'Brien, 2009, Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies, J. Lipid Res., 50, 2245, 10.1194/jlr.M900048-JLR200

Stasinopoulos, 2009, Inflammation, but not hypoxia, mediated HIF-1alpha activation depends on COX-2, Cancer Biol. Ther., 8, 31, 10.4161/cbt.8.1.7079

Oskouian, 2007, Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again, Cell Cycle, 6, 522, 10.4161/cc.6.5.3903

Gadiya, 2014, Phospholipase D1 and choline kinase-alpha are interactive targets in breast cancer, Cancer Biol. Ther., 15, 593, 10.4161/cbt.28165

Ackerstaff, 2003, Choline phospholipid metabolism: a target in cancer cells, J. Cell. Biochem., 90, 525, 10.1002/jcb.10659

Ramirez de Molina, 2002, Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy, Oncogene, 21, 4317, 10.1038/sj.onc.1205556

Lee, 2015, Uncovering unique roles of LPA receptors in the tumor microenvironment, Receptors Clin. Invest., 2

Leblanc, 2015, New insights into the autotaxin/LPA axis in cancer development and metastasis, Exp. Cell Res., 333, 183, 10.1016/j.yexcr.2014.11.010

Jankowski, 2011, Autotaxin: its role in biology of melanoma cells and as a pharmacological target, Enzyme Res., 2011, 194857, 10.4061/2011/194857

Mu, 2012, Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells, Am. J. Pathol., 180, 2170, 10.1016/j.ajpath.2012.03.003

Kishi, 2006, Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid, J. Biol. Chem., 281, 17492, 10.1074/jbc.M601803200

Mukherjee, 2012, Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells, J. Biol. Chem., 287, 24990, 10.1074/jbc.M112.340083

Hu, 2001, Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells, J. Natl. Cancer Inst., 93, 762, 10.1093/jnci/93.10.762

Boucharaba, 2009, Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms, Oncol. Res., 18, 173, 10.3727/096504009790217399

Yu, 2008, Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells, J. Natl. Cancer Inst., 100, 1630, 10.1093/jnci/djn378

Shah, 2005, Mechanisms of extracellularly regulated kinases 1/2 activation in adrenal glomerulosa cells by lysophosphatidic acid and epidermal growth factor, Mol. Endocrinol., 19, 2535, 10.1210/me.2005-0082

Nath, 2001, Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase, J. Cell Sci., 114, 1213, 10.1242/jcs.114.6.1213

Umata, 2004, Mechanism for activation of heparin-binding EGF-like growth factor induced by stimuli, J. UOEH, 26, 85, 10.7888/juoeh.26.85

Goetzl, 1999, Lysophospholipid enhancement of human T cell sensitivity to diphtheria toxin by increased expression of heparin-binding epidermal growth factor, Proc. Assoc. Am. Physicians, 111, 259, 10.1046/j.1525-1381.1999.99116.x

Tsoupras, 2009, The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants, Infect. Disord. Drug Targets, 9, 390, 10.2174/187152609788922555

Mills, 2003, The emerging role of lysophosphatidic acid in cancer, Nat. Rev. Cancer, 3, 582, 10.1038/nrc1143

Yap, 2015, Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma, J. Pathol., 235, 456, 10.1002/path.4460

Deo, 2004, Activation of platelet-activating factor receptor-coupled G alpha q leads to stimulation of Src and focal adhesion kinase via two separate pathways in human umbilical vein endothelial cells, J. Biol. Chem., 279, 3497, 10.1074/jbc.M304497200

Rodrigues, 2015, Blood cells and endothelial barrier function, Tissue Barriers, 3, e978720, 10.4161/21688370.2014.978720

Janakiram, 2016, Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer, Cancer Metastasis Rev., 30, 507, 10.1007/s10555-011-9311-2

Tsoupras, 2012, Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patients, Angiology, 63, 343, 10.1177/0003319711420608

Gelbard, 1994, Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin, J. Virol., 68, 4628, 10.1128/jvi.68.7.4628-4635.1994

Souza, 2009, Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection, Proc. Natl. Acad. Sci. U. S. A., 106, 14138, 10.1073/pnas.0906467106

Caini, 2007, Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection, J. Viral Hepat., 14, 22, 10.1111/j.1365-2893.2006.00766.x

Lima, 2006, Interaction of macrophages with apoptotic cells enhances HIV Type 1 replication through PGE2, PAF, and vitronectin receptor, AIDS Res. Hum. Retroviruses, 22, 763, 10.1089/aid.2006.22.763

Villani, 1991, Respiratory syncytial virus infection of human mononuclear phagocytes stimulates synthesis of platelet-activating factor, J. Biol. Chem., 266, 5472, 10.1016/S0021-9258(19)67619-2

Renda, 2010, Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors, Br. J. Clin. Pharmacol., 69, 303, 10.1111/j.1365-2125.2009.03579.x

Romano, 2010, Lipoxin and aspirin-triggered lipoxins, ScientificWorldJournal, 10, 1048, 10.1100/tsw.2010.113

Claria, 1995, Proc. Natl. Acad. Sci. U. S. A., 92, 9475, 10.1073/pnas.92.21.9475

Maddox, 1997, Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor, J. Biol. Chem., 272, 6972, 10.1074/jbc.272.11.6972

Takano, 1997, Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors, J. Exp. Med., 185, 1693, 10.1084/jem.185.9.1693

Corminboeuf, 2015, FPR2/ALXR agonists and the resolution of inflammation, J. Med. Chem., 58, 537, 10.1021/jm501051x

Chiang, 2000, Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation, J. Exp. Med., 191, 1197, 10.1084/jem.191.7.1197

Chandrasekharan, 2015, Lipoxins: nature's way to resolve inflammation, J. Inflamm. Res., 8, 181

Marginean, 2015, Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells, Transl. Res., 166, 111, 10.1016/j.trsl.2015.02.009

Fierro, 2002, Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4), J. Pharmacol. Exp. Ther., 300, 385, 10.1124/jpet.300.2.385

Morita, 2013, The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza, Cell, 153, 112, 10.1016/j.cell.2013.02.027

Pacholska, 2012, Increased invasion of malignant gliomas after 15-LO-1 and HSV-tk/ganciclovir combination gene therapy, Cancer Gene Ther., 19, 870, 10.1038/cgt.2012.76

Hayden, 2011, Emerging influenza antiviral resistance threats, J. Infect. Dis., 203, 6, 10.1093/infdis/jiq012

Imai, 2015, Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection, Biochim. Biophys. Acta, 1851, 496, 10.1016/j.bbalip.2015.01.006

Viita, 2012, 15-Lipoxygenase-1 induces lipid peroxidation and apoptosis, and improves survival in rat malignant glioma, In Vivo, 26, 1

Singh, 2011, The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth, Cancer Res., 71, 3268, 10.1158/0008-5472.CAN-10-2769

Tam, 2013, Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation, Cell, 154, 213, 10.1016/j.cell.2013.05.052

Borchers, 2013, Respiratory syncytial virus–a comprehensive review, Clin. Rev. Allergy Immunol., 45, 331, 10.1007/s12016-013-8368-9

Shirey, 2014, Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology, Mucosal Immunol., 7, 549, 10.1038/mi.2013.71

Knickelbein, 2009, Management of herpes simplex virus stromal keratitis: an evidence-based review, Surv. Ophthalmol., 54, 226, 10.1016/j.survophthal.2008.12.004

Rajasagi, 2011, Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1, J. Immunol., 186, 1735, 10.4049/jimmunol.1003456

Celik, 2002, Effects of ibuprofen on the physiology and outcome of rabbit endotoxic shock, BMC Infect. Dis., 2, 26, 10.1186/1471-2334-2-26

Grzesik, 2015, Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes, J. Clin. Endocrinol. Metab., 100, E387, 10.1210/jc.2014-3630

Szabo, 2014, Gastric cytoprotection is still relevant, J. Gastroenterol. Hepatol., 29, 124, 10.1111/jgh.12735

Horrillo, 2007, Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor, J. Pharmacol. Exp. Ther., 323, 778, 10.1124/jpet.107.128264

Thông tin
Thông tin xuất bản

Prostaglandins & Other Lipid Mediators

Tập 126

46-54

Thông tin tác giả